Furthermore, in those with histoplasmosis, HAART was also associated with a significant reduction of death at 6 months (adjusted HR = 0.2 (0.0 to 0.5), P = 0.003) after adjusting for age, sex, CD4, and CD8 counts [6]. This evidence concerns the gene CD4 and histoplasmosis.